Itch, Papain, Skin Prick Test (SPT)
Conditions
Brief summary
In this experiment the investigators would like to test a new new human itch model based on papain, and to characterize the sensory quality and temporary aspects of papain skin prick test (SPT) in comparison to the inactivated-cowhage delivery system.
Detailed description
The most used model of non-histaminergic itch is cowhage but this models presents several problems, such us the impossibility of standardizing the amount of the spicules inserted in the skin and the difficulty of obtaining the substance. These aspects bring us the necessity to find a new and more standardized model of non-histaminergic itch. Papain is a cysteine protease extracted from papaya plant that is known to cause itch if applied to the skin. For these reasons the investigators would like to test a new new human itch model based on papain, and to characterize the sensory quality and temporary aspects of papain skin prick test (SPT) in comparison to the inactivated-cowhage delivery system.
Interventions
DRUGPapain 10 µg
The area will be exposed to 10 µg of papain.
DRUGPapain 50 µg
The area will be exposed to 50 µg of papain.
DRUGPapain 100 µg
The area will be exposed to 100 µg of papain.
OTHERVehicle
The area will be exposed to vehicle
DRUGPapain 1 SPT
Papain will be applied by 1 SPT prick thought the skin
DRUGPapain 5 SPT
Papain will be applied by 5 SPT pricks thought the skin
DRUGPapain 25 SPT
Papain will be applied by 25 SPT pricks thought the skin
OTHERCowhage
The last area will be exposed to cowage spicules (made chemically inert by autoclaving) soaked in 5 mg/ml papain solution.
Sponsors
Aalborg University
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Healthy men and women * 18-60 years * Speak and understand English
Exclusion criteria
* Pregnancy or lactation * Drug addiction defined as any use of cannabis, opioids or other addictive drugs * Previous or current history of neurological, dermatological, immunological musculoskeletal, cardiac disorder or mental illnesses that may affect the results (e.g. neuropathy, muscular pain in the upper extremities, etc.). * Lack of ability to cooperate * Current use of medications that may affect the trial such as antihistamines, antipsychotics and pain killers, as well as systemic or topical steroids. * Skin diseases * Moles, scars or tattoos in the area to be treated or tested. * Hypersensitivity to papaya and mango fruit, cashew nuts, rubber latex * Consumption of alcohol or painkillers 24 hours before the study days and between these * Acute or chronic pain * Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical trials)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Superficial blood perfusion | 15 minutes | Superficial blood perfusion is measured by a Speckle contrast imager (FLPI, Moor Instruments, England). |
| Measuring itch intensity by computerized Visual Analog Scale Scoring | 15 minutes | The subjects will rate the sensation of itch on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates no itch and 100 indicates worst itch imaginable and similarly for sensations of stinging/pricking and burning, both of which are frequently associated with the sensation of itch. |
| Measuring pain intensity by computerized Visual Analog Scale Scoring | 15 minutes | The subjects will rate the sensation of pain on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates no pain and 100 indicates worst pain imaginable. |
| Measuring Alloknesis | 15 minutes | Alloknesis is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 milliNewton of force). This stimulator is applied 0.5 cm outside the area of itch provocation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of Pain to Supra-threshold Heat Stimuli | 15 minutes | The tests will be conducted by using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device. A thermode stimulator of 3x3 cm will be placed on the treated/placebo areas and kept in place by means of Velcro tape. The subjects will have to rate the pain to two suprathreshold heat pain stimuli (starting and ending at 32°C with an increase and decrease of 5°C and 3 s plateau at 50°C). |
| Measurement of Mechanical Pain Thresholds (MPT) | 15 minutes | This test is conducted using a pin-prick set (Aalborg University, Aalborg). |
| Measurement of Cold Detection Thresholds (CDT) | 15 minutes | The tests for thermal sensation will all be conducted using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device. A thermode stimulator of 3x3 cm will be placed on the treated/placebo areas and kept in place by means of Velcro tape. During the first 8 seconds, the temperature decreases 1°C per second from a starting temperature of 32°C until the subject perceives a temperature change (cold sensation) and presses a button that will terminate the measurement and return the temperature to baseline at a rate of 5°C /s. A cut-off temperature of 0°C will be used. |
| Touch Pleasantness (TP) | 15 minutes | Pleasant touch sensation measured using a standardized sensory brush (SENSELab Brush-05, Somedic AB, Hörby, Sweden) exerting a force of 200 to 400 mN. |
| Measurement of Mechanical Pain Sensitivity (MPS) | 15 minutes | This test is conducted using a pin-prick set (Aalborg University, Aalborg). |
| Measurement of Cold Pain Thresholds (CPT) | 15 minutes | The tests for thermal sensation will all be conducted using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device. A thermode stimulator of 3x3 cm will be placed on the treated/placebo areas and kept in place by means of Velcro tape. During the first 8 seconds, the temperature decreases 1°C per second from a starting temperature of 32°C until the subject perceives a temperature change (cold sensation) and presses a button that will terminate the measurement and return the temperature to baseline at a rate of 5°C /s. A cut-off temperature of 0°C will be used. |
| Measurement of Warm Detection Thresholds (WDT) | 15 minutes | The tests for thermal sensation will all be performed using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device. A thermode stimulator of 3x3 cm will be placed on the treated/placebo areas and kept in place by means of Velcro tape. During the first 8 seconds, the temperature raises 1°C per second from a starting temperature of 32°C until the subject detects a painful sensation and presses a button that will terminate the measurement and return the temperature to baseline at a rate of 5°C /s. A cut-off temperature of 52°C will be used. |
| Measurement of Heat Pain Thresholds (HPT) | 15 minutes | The tests for thermal sensation will all be performed using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device. A thermode stimulator of 3x3 cm will be placed on the treated/placebo areas and kept in place by means of Velcro tape. During the first 8 seconds, the temperature raises 1°C per second from a starting temperature of 32°C until the subject detects a painful sensation and presses a button that will terminate the measurement and return the temperature to baseline at a rate of 5°C /s. A cut-off temperature of 52°C will be used. |
Countries
Denmark
Outcome results
None listed